The assay in question is called PubChem BioAssay, and it uses a fluorescence polarization assay to screen for inhibitors that compete with the binding of FadD28 to a bisubstrate. This particular assay is classified as confirmatory, and it has a homologous single protein target assigned. Some of the properties of this assay include its confirmation category, which means it is used to validate other assays, and its assay organism, which is Mycobacterium tuberculosis H37Rv. In addition, the assay type description is functional, meaning it assesses the impact of certain compounds on the activity of the target protein. The specific code for the assay is 2147-01_Inhibitor_Dose_CherryPick_Activity. Does this molecule show efficacy in this assay?